Skip to search formSkip to main contentSkip to account menu

indobufen

Known as: 2-(4-(1-oxo-2-isoindolinyl)phenyl)butyric acid, 4-(1,3-Dihydro-1-oxo-2H-isoindol-2-yl)-alpha-ethylbenzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl) alpha- ethylbenzeneacetic acid 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (4)

Cyclooxygenase InhibitorsIsoindolesPhenylbutyratesPlatelet Aggregation Inhibitors

Narrower (2)

IbustrinK 3920
Indobufen Sodium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Computational analysis of aspartic protease plasmepsin II complexed with EH58 inhibitor: a QM/MM MD study
AbstractPlasmepsin (PM) II is one of four enzymes in the food vacuole of Plasmodium falciparum. It has become an attractive… 
2004
2004
High-pressure liquid chromatographic determination of acetylsalicylic acid, salicylic acid, diflunisal, indomethacin, indoprofen and indobufen
SummaryA high-pressure liquid chromatographic technique was developed which allowed concurrent measurement of acetylsalicylic… 
1997
1997
A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study.
Two treatments, based on either ticlopidine or indobufen at their optimal individual daily dose (median dose: 250 and 200 mg/day… 
1993
1993
Inhibition of thromboxane biosynthesis and platelet function by indobufen in type II diabetes mellitus.
Indobufen is a reversible inhibitor of platelet prostaglandin G/H-synthase. To verify the dose dependence of the antiplatelet… 
1991
1991
Long-Term Evaluation of Indobufen in Peripheral Vascular Disease
Indobufen—an inhibitor of platelets aggregation—has been used in 306 pa tients with intermittent claudication due to peripheral… 
1991
1991
Indobufen versus Placebo in the Prevention of Restenosis after Carotid Endarterectomy: A Double-Blind Pilot Study
A randomized clinical trial was undertaken to assess the efficacy of indobufen in inhibiting platelet adhesiveness in carotid… 
1987
1987
In vitro and ex vivo effects of indobufen on human platelet aggregation, the release reaction and thromboxane B2 production.
We have done a comprehensive study in normal volunteers of the in vitro and ex vivo effects of the antiplatelet agent indobufen… 
1986
1986
Low dose aspirin does not prevent fibrinolytic response to venous occlusion.
1984
1984
Indobufen interacts with the sulphonylurea, glipizide, but not with the beta-adrenergic receptor antagonists, propranolol and atenolol.
This study assessed the possible interactions of the cyclooxygenase inhibitor indobufen with one sulphonylurea, glipizide, and… 
1979
1979
Indobufen (K 3920), a new inhibitor of platelet aggregation: Effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man
SummaryThe effect of food on bioavailability of indobufen tablets was investigated in 6 healthy volunteers. Subsequently, the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)